Healthy Extracts

When 40 Million Followers Meet a Manufacturing Floor: Inside the Imaraïs Beauty Acquisition

When 40 Million Followers Meet a Manufacturing Floor: Inside the Imaraïs Beauty Acquisition

OTC: HYEX

The Deal

On May 18, Healthy Extracts Inc. (OTCQB: HYEX) announced the acquisition of Imaraïs Beauty, the ingestible beauty brand co-founded by fitness influencer Sommer Ray and supplement industry veteran Aaron Hefter, in a transaction valued at approximately $20 million. The deal, structured as a mix of equity, cash, and HYEX common stock, marks one of the most notable micro-cap moves in the beauty-from-within space this year.

It also tells a larger story about where influencer brands go after the hype cycle, and why manufacturing discipline might be the real currency in wellness M&A.

The Brand Behind the Buzz

Imaraïs Beauty launched in 2021 out of Toronto with a simple thesis: beauty starts with what you put in your body, not just on it. Co-founded by Sommer Ray, whose combined social following exceeds 40 million across Instagram, TikTok, and YouTube, the brand entered a crowded supplement market with a differentiator that went beyond celebrity endorsement.

The products, a line of seven ingestible beauty gummies featuring clinically proven, PETA-certified vegan formulations, earned shelf space where it counts. Imaraïs is currently stocked in Ulta Beauty, Target, Nordstrom, and Sprouts Farmers Market, with distribution spanning the United States, Canada, and the United Kingdom. The brand’s Glow gummies, built on marine algae, Activated-C, and proprietary Vegan Squalane, became the entry point for a broader wellness lineup that now includes Nourish, Youth, DePuff, and Sutra.

What made Imaraïs unusual in the influencer-brand landscape is how little capital it required to reach scale. According to Beauty Independent, the company had raised only approximately $400,000 prior to the acquisition, an almost unheard-of figure for a brand with that retail footprint. As Hefter put it: “Influence can introduce the consumer, but efficacy and experience keep the consumer.”

The Acquirer’s Playbook

Healthy Extracts is not a household name, but Don Swanson, the company’s Chairman and CEO, is building something with familiar ambitions. A manufacturing engineer by training, Swanson founded Gummy USA in 2021 and developed the patent-pending SureDose technology, a precision-dosing system designed to bring pharmaceutical-grade accuracy to gummy supplements.

The Gummy USA merger with Healthy Extracts brought manufacturing infrastructure, R&D capability, and a Florida production facility into the fold. The result: 2025 net revenue climbed 45% to a record $4.5 million, driven by expanded distribution channels and a growing direct-to-consumer business.

The Imaraïs acquisition accelerates that trajectory considerably. Management projects a combined annualized revenue run rate of approximately $24 million by year-end 2026, scaling to more than $55 million in 2027. Swanson has been candid about his ambitions, telling Beauty Independent, “My wish is to build a billion-dollar market cap company.” For context, HYEX’s current market capitalization sits near $21 million.

The strategic logic is straightforward: Imaraïs brings retail velocity, cultural relevance, and consumer reach. Healthy Extracts brings formulation discipline, manufacturing scale, and IP. “I’ve never seen another manufacturer so committed about the back end as we are at the front end,” Hefter said of the match.

Riding the Beauty-From-Within Wave

This deal does not exist in isolation. The global beauty ingestibles market, valued at approximately $3.56 billion in 2024, is projected to reach $9.22 billion by 2032, growing at a compound annual rate of 11.4%, according to Verified Market Research. Gummies and chewables represent the fastest-growing product format in the category.

The transaction also joins a wave of beauty-wellness M&A that has picked up significantly in 2026:

  • Unilever acquired Grüns, the supplement gummy brand, for $1.2 billion
  • Herbalife purchased Bioniq for a reported sum of up to $150 million
  • Marubeni Corporation moved to acquire J-beauty brand Etvos to build what it calls a “Beauty and Health business platform”

As Personal Care Insights reported, retailers from Ulta to Boots are expanding dedicated wellness sections in-store, curating by function rather than brand. The lines between beauty counter and supplement aisle continue to blur. One industry founder quoted in the report captured the shift: “Consumers don’t necessarily want more wellness routines. They want support that fits naturally into real life.”

The Near-Term Catalysts

The most immediate growth driver is a nationwide CVS Pharmacy rollout launching next month, placing five of Imaraïs’s seven products in over 4,400 locations as part of CVS’s “Trending Supplements” endcap program. That effectively doubles the brand’s total retail door count to approximately 8,000.

Beyond CVS, Swanson noted a July meeting with Amazon to discuss expanded distribution, and Sommer Ray, who assumes the title of Chief Innovation Officer post-acquisition, will continue to drive consumer awareness through her platforms. The company has also signaled plans to expand into hydration, stress, sleep, women’s wellness, and healthy aging formulations, leveraging Healthy Extracts’ SureDose manufacturing technology.

The acquisition is also viewed as a step toward a potential NASDAQ uplisting, which would broaden the company’s investor access and institutional visibility.

ArcStone’s View

The Healthy Extracts acquisition of Imaraïs Beauty represents a disciplined strategic move that combines established retail distribution with proprietary manufacturing capabilities. The deal positions the combined entity at the intersection of two powerful trends: the maturation of influencer-founded brands into institutional-grade consumer platforms, and the rapid growth of the beauty-from-within category.

At a ~$20 million valuation for a brand with national retail placement in Ulta, Target, Nordstrom, and an imminent CVS rollout, the transaction appears to carry a modest price relative to the distribution infrastructure being acquired. The revenue trajectory from $4.5 million to a projected $24 million run rate within a single year warrants close monitoring.

Sources

Coverage of this transaction was featured across industry and financial publications:

Disclaimer and Forward-Looking Statements

The information contained herein is provided by ArcStone Securities and Investments Corp. (“ArcStone”) for informational purposes only. It is not, and under no circumstances should it be construed as, an offer to sell or a solicitation of an offer to buy any securities or other financial instruments in any jurisdiction.

Certain statements contained herein may constitute “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements are based on current expectations, estimates, and assumptions that involve known and unknown risks and uncertainties which may cause actual results or developments to differ materially from those expressed or implied. These statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “project,” “should,” “target,” or similar expressions. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Except as required by law, ArcStone undertakes no obligation to update or revise any forward-looking information.

This content is not intended as investment advice or a recommendation to buy or sell any security and does not take into account the investment objectives, financial situation, or needs of any individual. Investors should consult their own professional advisors before making any investment decisions.

ArcStone Securities and Investments Corp. is not a registered broker-dealer and does not provide investment advice or recommendations. All registrable activities in the United States are conducted through ArcStone Securities, LLC and Kingswood US, both FINRA-registered broker-dealers. Healthy Extracts Inc. (OTCQB: HYEX) is a current client of ArcStone Securities, LLC (“ASLLC”), a wholly owned subsidiary of ArcStone. ASLLC maintains an active equity capital markets engagement with the Company and receives a monthly expense reimbursement as well as success-based compensation tied to capital raises, which may include cash fees and warrants. ArcStone and/or its affiliates have previously received restricted shares in connection with advisory services provided to the Company. This relationship represents a material conflict of interest, as ArcStone may be perceived to have a financial incentive to present the Company in a favorable light. The principals, directors, officers, employees, and related entities of ArcStone and its affiliates may, from time to time, own, buy, or sell securities or derivatives of the Company or its affiliates.

Read more